Large-scale,multicentre,quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

Abstract

Although the mechanisms underlying the accumulation of disability in primary progressive (PP) multiple sclerosis (MS) are still unclear, a major role seems to be played by `occult' tissue damage. We investigated whether conventional and magnetization transfer (MT) MRI may provide complementary information for the assessment of PPMS severity. Conventional and MT MRI scans from 226 PPMS patients and 84 healthy controls were collected for centralized analysis. The expanded disability status scale (EDSS) score was rated at the time of MRI acquisition. T2 lesion volume, normalized brain volume (NBV) and cervical cord cross-sectional area (CSA) were measured. Magnetization transfer ratio (MTR) histograms from whole brain tissue, normal-appearing white matter and grey matter (NAGM) were also obtained. Mean NBV, CSA and MTR histogram-derived metrics showed significant inter-centre heterogeneity. After correcting for the acquisition centre, pooled average MTR and histogram peak height values were different between PPMS patients and controls for all tissue classes (P-values between 0.03 and 0.0001). More severe brain and cord atrophy and MT MRI-detectable NAGM damage were found in patients who required walking aids than in those who did not (P-values: 0.03, 0.001 and 0.016). A composite score of NBV, CSA, whole brain and NAGM MTR histogram peak height z-scores was correlated with patients' EDSS (r = 0.37, P 0.001). Magnetization transfer MRI might provide information complementary to that given by conventional MRI when assessing PPMS severity. Sequence-related variability of measurements makes the standardization of MT MRI acquisition essential for the design of multicentre studies. Multiple Sclerosis 2008; 14: 455—464. http://msj.sagepub.com

Keywords

atrophy MRI primary progressive multiple sclerosis grey matter

Get full access to this article

View all access options for this article.

References

Thompson AJ , Kermode AG , MacManus DG , Kendall BE , Kingsley DP , Moseley IF Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study . Br Med J 1990; 300: 631-4.

Thompson AJ , Kermode AG , Wicks D. , MacManus DG , Kendall BE , Kingsley DP Major differences in the dynamics of primary and secondary progressive multiple sclerosis . Ann Neurol 1991; 29: 53-62.

Kidd D. , Thorpe JW , Kendall BE , Barker GJ , Miller DH , McDonald WI MRI dynamics of brain and spinal cord in progressive multiple sclerosis J Neurol Neurosurg Psychiatry 1996; 60: 15-9.

Lycklama à Nijeholt GJ , Van Walderveen MAA , Castelijins JA , van Waesberghe Jhtm , Polman C. , Scheltens P. et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms . Brain 1998; 121: 687-97.

Stevenson VL , Miller DH , Rovaris M. , Barkhof F. , Brochet B. , Dousset V. et al. Primary and transitional progressive MS. A clinical and MRI cross-sectional study . Neurology 1999; 52: 839-45.

van Walderveen MA , Lycklama à Nijeholt GJ , Ader HJ , Jongen PJ , Polman CH , Castelijns JA Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging. Relation to clinical characteristics in subgroups of patients with multiple sclerosis . Arch Neurol 2001; 58: 76-81.

Kalkers NF , Barkhof F. , Bergers E. , van Schijndel R. , Polman CH The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study . Mult Scler 2002; 8: 532-3.

Leary SM , Miller DH , Stevenson VL , Brex PA , Chard DT , Thompson AJ Interferon β-1a in primary progressive MS. An exploratory, randomised, controlled trial . Neurology 2003; 60: 44-51.

Wolinsky JS , Narayana PA , O'Connor P. , Coyle PK , Ford C. , Johnson K. et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial . Ann Neurol 2007; 61: 14-24.

10.

Bozzali M. , Cercignani M. , Sormani MP , Comi G. , Filippi M. Quantification of brain grey matter damage in different MS phenotypes by use of diffusion tensor MR imaging . AJNR Am J Neuroradiol 2002; 23: 985-8.

11.

Dehmeshki J. , Chard DT , Leary SM , Watt HC , Silver NC , Tofts PS et al. The normal appearing grey matter in primary progressive multiple sclerosis. A magnetisation transfer imaging study . J Neurol 2003; 250: 67-74.

12.

Rovaris M. , Bozzali M. , Santuccio G. , Ghezzi A. , Caputo D. , Montanari E. et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis . Brain 2001; 124: 2540-9.

13.

Rovaris M. , Bozzali M. , Iannucci G. , Ghezzi A. , Caputo D. , Montanari E. et al. Assessment of normal-appearing white and grey matter in patients with primary progressive multiple sclerosis . Arch Neurol 2002; 59: 1406-12.

14.

Rovaris M. , Gallo A. , Falini A. , Benedetti B. , Rossi P. , Comola M. et al. Axonal injury and overall tissue loss are not related in primary progressive MS . Arch Neurol 2005; 62: 898-902.

15.

Rovaris M. , Gallo A. , Valsasina P. , Benedetti B. , Caputo D. , Ghezzi A. et al. Short-term accrual of grey matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI . NeuroImage 2005; 24: 1139-46.

16.

Ramiò-Torrentà L. , Sastre-Garriga J. , Ingle GT , Davies GR , Ameen V. , Miller DH Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study . J Neurol Neurosurg Psychiatry 2006; 77: 40-5.

17.

Vrenken H. , Pouwels PJW , Geurts JJG , Knol DL , Polman CH , Barkhof F. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration . J Magn Reson Imaging 2006; 23: 628-36.

18.

Kutzelnigg A. , Lucchinetti CF , Stadelmann C. , Brueck W. , Rauschka H. , Bergmann M. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis . Brain 2005; 128: 2705-12.

19.

Bieniek M. , Altmann DR , Davies GR , Ingle GT , Rashid W. , Sastre-Garriga J. et al. Cord atrophy separates early primary progressive and relapsing remitting MS . J Neurol Neurosurg Psychiatry 2006; 77: 1036-9.

20.

van Waesberghe JH , Kamphorst W. , DeGroot CJ , van Walderveen MA , Casteljins JA , Ravid R. et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability . Ann Neurol 1999; 46: 747-54.

21.

Schmierer K. , Scaravilli F. , Altmann DR , Barker GJ , Miller DH Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain . Ann Neurol 2004; 56: 407-15.

22.

Leary SM , Silver NC , Stevenson VL , Barker GJ , Miller DH , Thompson AJ Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis . Mult Scler 1999; 5: 313-6.

23.

Filippi M. , Iannucci G. , Tortorella C. , Minicucci L. , Horsfield MA , Colombo B. et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI . Neurology 1999 ; 52: 588-94.

24.

Tortorella C. , Viti B. , Bozzali M. , Sormani MP , Rizzo G. , Gilardi MF et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS . Neurology 2000; 54: 186-93.

25.

Kalkers NF , Hintzen RQ , van Waesberghe JH , Lazeron RHC , van Schijndel RA , Ader HJ et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy . J Neurol Sci 2001; 184: 155-62.

26.

Inglese M. , van Waesberghe JH , Rovaris M. , Beckmann K. , Barkhof F. , Hahn D. et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS . Neurology 2003; 60: 853-60.

27.

Filippi M. , Rocca MA , Pagani E. , Iannucci G. , Sormani MP , Fazekas F. et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis . Arch Neurol 2004; 61: 1409-12.

28.

Wolinsky JS , Narayana PA , Noseworthy JH , Lublin FD , Whitaker JN , Linde A. et al. Linomide in relapsing and secondary progressive MS: part II: MRI results . Neurology 2000; 54: 1734-41.

29.

Thompson AJ , Polman CH , Miller DH , McDonald WI , Brochet B. , Filippi M. et al. Primary progressive multiple sclerosis . Brain 1997 ; 120: 1085-96.

30.

Kurtzke JF Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-52.

31.

Miller DH , Barkhof F. , Berry I. , Kappos L. , Scotti G. , Thompson AJ Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted Action Guidelines . J Neurol Neurosurg Psychiatry 1991; 54: 683-8.

32.

Rovaris M. , Filippi M. , Calori G. , Campi A. , Rodegher M. , Colombo B. et al. Intra-observer reproducibility in measuring new putative markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images . J Neurol 1997; 244: 266-70.

33.

Smith SM , Zhang Y. , Jenkinson M. , Chen J. , Matthews PM , Federico A. et al. Accurate, robust and automated longitudinal and cross-sectional brain change analysis . NeuroImage 2002; 17: 479-89.

34.

Zivadinov R. , Grop A. , Sharma J. , Bratina A. , Tjoa CW , Dwyer M. et al. Reproducibility and accuracy of quanti-tative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis . J Neuroimag 2005; 15: 27-36.

35.

Agosta F. , Rovaris M. , Pagani E. , Sormani MP , Comi G. , Filippi M. Magnetisation transfer MRI metrics predict the accumulation of disability eight years later in patients with multiple sclerosis . Brain 2006; 129: 2620-7.

36.

Sormani MP , Iannucci G. , Rocca MA , Mastronardo G. , Cercignani M. , Minicucci L. et al. Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers . AJNR Am J Neuroradiol 2000; 21: 133-6.

37.

Chard DT , Parker GJ , Griffin CMB , Thompson AJ , Miller DH The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology . J Magn Reson Imag 2002; 15: 259-67.

38.

Losseff NA , Webb SL , O'Riordan JI , Page R. , Wang L. , Barker GJ et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression . Brain 1996; 119: 701-8.

39.

Savitz DA , Olshan AF Describing data requires no adjustment for multiple comparisons: a reply from Savitz and Olshan . Am J Epidemiol 1998; 147: 813-4.

40.

Thompson J.

Invited commentary: Re: `Multiple comparisons and related issues in the interpretation of epidemiologic data'

Am J Epidemiol 1997; 147: 801-6.

41.

Polman CH , Reingold SC , Edan G. , Filippi M. , Hartung HP , Kappos L. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the `McDonald Criteria' . Ann Neurol 2005; 58: 840-6.

42.

Cottrell DA , Kremenchutzky M. , Rice GPA , Koopman WJ , Hader W. , Baskerville J. , Ebers GC The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis . Brain 1999; 122: 625-39.

43.

Confavreux C. , Vukusic S. Natural history of multiple sclerosis: a unifying concept . Brain 2006; 129: 606-16.

44.

Sastre-Garriga J. , Ingle GT , Chard DT , Ramio-Torrenta L. , Miller DH , Thompson AJ Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis . NeuroImage 2004; 22: 353-9.

45.

Sastre-Garriga J. , Ingle GT , Chard DT , Cercignani M. , Ramio-Torrenta L. , Miller DH et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study . Brain 2005; 128: 1454-60.

46.

Ropele S. , Filippi M. , Valsasina P. , Korteweg T. , Barkhof F. , Tofts PS et al. Assessment and correction of B1-induced errors in magnetization transfer ratio measurements . Magn Reson Med 2005; 53: 134-40.

47.

Frohman EM , Stuve O. , Havrdova E. , Corboy J. , Achiron A. , Zivadinov R. et al. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience and future expectations . Arch Neurol 2005; 62: 1519-30.

48.

Rovaris M. , Judica E. , Gallo A. , Benedetti B. , Sormani MP , Caputo D. et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years . Brain 2006; 129: 2628-34.

49.

Sastre-Garriga J. , Ingle GT , Chard DT , Ramio-Torrenta L. , McLean MA , Miller DH et al. Metabolite changes in normal-appearing grey and white matter are linked with disability in early primary progressive multiple sclerosis . Arch Neurol 2005; 62: 569-73.

50.

Ingle GT , Sastre-Garriga J. , Miller DH , Thompson AJ Is inflammation important in early PPMS? A longitudinal MRI study . J Neurol Neurosurg Psychiatry 2005; 76: 1255-8.

51.

Lycklama à Nijeholt GJ , Bergers E. , Kamphorst W. , Bot J. , Nicolay K. , Casteljins JA et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis. A correlative study with conventional MRI, histopathology and clinical phenotype . Brain 2001; 124: 154-66.

52.

Camp SJ , Stevenson VL , Thompson AJ , Miller DH , Borras C. , Auriacombe S. et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates . Brain 1999; 122: 1341-8.

53.

Li DKB , Held U. , Petkau J. , Daumer M. , Barkhof F. , Fazekas F. et al. MRI T2 lesion burden in multiple sclerosis. A plateauing relationship with clinical disability . Neurology 2006; 66: 1384-9.

54.

Filippi M. , Rocca MA , Falini A. , Caputo D. , Ghezzi A. , Colombo B. et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS . NeuroImage 2002; 15: 537-46.

55.

Rocca MA , Matthews PM , Caputo D. , Ghezzi A. , Falini A. , Scotti G. et al. Evidence for widespread movement-associated functional MRI changes in patients with PPMS . Neurology 2002; 58: 866-72.